---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-003837"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2025-11-14T23:59:59+00:00"
generated_at: "2026-05-16T19:51:42.503808+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lifeward Q3 revenue $6.2M (+1% YoY); net loss $0.20/shr; secures $3M loan from Oramed

## Summary
- Revenue $6.2M (+1% YoY); traditional products up 24% to $3.1M; AlterG down 15% to $3.1M.
- GAAP net loss $3.2M ($0.20/shr); non-GAAP net loss $3.0M ($0.19/shr) vs $4.0M ($0.45/shr) YoY.
- Cash used in ops $3.8M (down from $4.5M YoY); unrestricted cash $2.0M at quarter end.
- Entered $3.0M secured loan from Oramed at 15%, convertible at $0.45/shr, matures May 2026.
- Reaffirmed FY2025 guidance: revenue $24-26M; non-GAAP net loss $12-14M.

## SEC filing metadata
- accession: 0001178913-25-003837
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2025-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.02, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891325003837/0001178913-25-003837-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891325003837/zk2534022.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-003837
- JSON: https://secwatch.observer/filing/0001178913-25-003837.json
- Plain text: https://secwatch.observer/filing/0001178913-25-003837.txt

## Key facts
- Debt Financings
  Lifeward Ltd. incurred loan of $3.0 million with Oramed Ltd. at 15% per annum maturing May 14, 2026.
  - Instrument: loan
  - Principal: $3.0 million
  - Counterparty: Oramed Ltd.
  - Rate: 15% per annum
  - Maturity: May 14, 2026
  - Event: incurrence
  source text: On November 14, 2025, Lifeward Ltd. (the “Company,” “we” or “us”) entered into a Secured Promissory Note (the “Secured Promissory Note”) with Oramed Ltd. (“Oramed”) pursuant to which, we issued to Oramed a secured promissory note in the principal amount of $3.0 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1607962/000117891325003837/0001178913-25-003837-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.